While breast implants have long been promoted as safe and effective, Breast Implant Safety Alliance (BISA) was published in an article that shines a light on the safety concerns and asks an important question: Are breast implants really as safe as we think? 

Are breast implants as safe as we think, and why do we still question the safety? Members of the Breast Implant Safety Alliance (BISA) reviewed a new article examining the reputation of the FDA concerning the safety of breast implants.

Save the date for the 10th International Breast Surgery Workshop (IBSW) and the 6th World Consensus Conference on BIA-ALCL, scheduled for April 11-12, 2025, in Tampa, Florida,

It was encouraging to see the FDA gather expert opinions along with patient advocates and advisors to create improved guidance on more patient-centered informed consent materials for potential participants considering involvement in a clinical study. BISA compiled a few takeaways after the meeting.

The Plastic Surgery Foundation is currently welcoming applications for breast implant safety. The deadline to apply is December 2, 2024.

Federal health regulators are alerting doctors to stop using BioZorb Markers due to reports of serious health problems among women who had these implants placed in their breast tissue for targeted cancer treatment.

BISA wants to keep women healthy, safe, and informed. How much do YOU really know about breast implants? Test you knowledge by taking our short quiz.

With Dr. Michelle Tarver’s appointment as the new director of CDRH, BISA hopes for stronger patient-focused oversight, contrasting with past controversies.

Interested in who we are, what we do and why we do it? This presentation will help you understand how we want to keep women safe, healthy and informed.

The 3rd Breast Implant Health Symposium is a virtual event designed for healthcare practitioners to discuss assessing and treating patients with breast implants on November 2 and 3, 2024.

BISA continues to empower women in local communities on breast cancer and breast implant safety with the 2nd "Knowledge is Beautiful" Awareness Event in Oregon.

The FDA welcomes participation during the October 30, 2024 Patient Engagement Advisory Committee (PEAC) meeting on patient-centered informed consent in clinical study of FDA-regulated medical products.

BISA wants to keep women healthy, safe, and informed. Here are 5 important things all women should know about breast implants.

The FDA has approved Motiva’s SmoothSilk Round and Round Ergonomix Silicone Gel-Filled Breast Implants for breast augmentation in people 22 and older.